While such scenario is possible, recent studies in BCAC have shown that besides ER/PR status, the interaction of low-penetarnt alleles from GWAS with other tumor characteristics is weaker [19], thus it is unlikely these would substantially impact the observed heterogeneity. The gene discussed is ESR1; the disease is neoplasm.